ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

Coalition Opens Web Site To Promote Cancer Trials.

June 15, 2001

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006

Eleven Chemicals Rated for Tests

September 1, 1978

Prime Contract Subcontract Opportunities

January 24, 1975

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986